Making Britain the Best Place to Grow Up and Grow Old

Debate between Jim Shannon and Nadhim Zahawi

Monday 16th May 2022 Commons Chamber

[The Secretary of State for Education (Nadhim Zahawi)]

It is a great honour for me to open this debate on the Loyal Address. In Her Majesty’s jubilee year, I want to thank her for her dedication and service to our country, the Commonwealth and all its people. That includes young immigrants arriving on these shores, who feel her warmth and generosity; of course, some of them end up as her Ministers. I also thank Prince Charles and Prince William, the Duke of Cambridge, for opening Parliament on her behalf.

During Her Majesty’s 70-year reign, this country has been the best place in the world to grow up and grow old, yet during these seven decades the British people have overcome major challenges, time and time again. We have just lived through what I am sure you will agree has been an incredibly difficult period, Madam Deputy Speaker. After years of sacrifice by people up and down the country, this Queen’s Speech focuses our attention exactly where it should be—on the future.

The future, full of promise, will not be without its challenges, both at home and overseas. Our country needed a Queen’s Speech that rises to the scale of the challenge we face, and we have delivered it. Our communities needed a Queen’s Speech that keeps them safe, secure and prosperous, and we will deliver it. Our constituents needed a Queen’s Speech that shows them that the door of opportunity is always open to them, and we will deliver it. Our relentless focus is on delivery, delivery, delivery.

Before I outline how our legislative programme will make sure that this country remains the best place to grow up and grow old, I reaffirm this Government’s solidarity with the people of Ukraine. I am pleased to say that all Ukrainian children and young people arriving in the United Kingdom have the right to access state education while in the UK. With memories of my own childhood, leaving Saddam Hussein’s Iraq and building a new life here, I know how important education is to helping young people integrate into their new communities.

[Jim Shannon (Strangford) (DUP)]

The Secretary of State is absolutely right to say that there is no better place in the world to live than this great United Kingdom of Great Britain and Northern Ireland—always better together. Can he confirm that through the Government’s policies and this Queen’s Speech, every step will be taken to ensure that every child in this United Kingdom of Great Britain and Northern Ireland achieves academic success; to improve the health system for every person who is on the waiting list; and to help every elderly person who depends on a better income for energy, food and heat?

[Nadhim Zahawi]

I think the hon. Gentleman speaks for the whole of Northern Ireland when he says that the focus has to be on the education, healthcare and public services that the people of Northern Ireland so badly need.

Not only do we need to make sure that Ukrainian refugees are well integrated, but we need to give them the same skills that we are giving our children, so that they can take on the challenges of the future.

Not only do we need to make sure that Ukrainian refugees are well integrated, but we need to give them the same skills that we are giving our children, so that they can take on the challenges of the future. I want to take this opportunity to commend schools and local authorities across England for rising to the challenge of welcoming and supporting children arriving from Ukraine, and offering thousands of them a school place, in the same schools that are at the heart of our plans to level up. One of the first Bills introduced this Session, in the other place, is the Schools Bill, which will deliver a stronger schools system that works for every child, no matter where they were born or live in our country. It will work alongside close to £5 billion of investment in our ambitious multi-year educational recovery plan, investing in what we know works: teacher training; tutoring; and extra educational opportunities, including of course extra hours for those who have the least time left in education—the 16 to 19-year-old students.

The evidence is clear that our plan is working and the recovery is happening, with primary pupils recovering about 0.1 months in reading and 0.9 months in maths since the summer. Combined with our £7 billion cash increase in the total core schools budget by 2024-25—this is compared not with 10 years ago but with 2021-22—this means we are giving schools the resources they need to focus on student outcomes. It is money that will help schools increase teachers’ pay, including by delivering on our manifesto pledge of a £30,000 starting salary. This is money that will help schools deliver resources for students and meet inflationary pressures in these uncertain times.

However, there is more to do, because too many children leave primary school unable to meet the expected standards in reading, writing and mathematics, despite the remarkable progress in the past decade. Through our Bill, 90% of primary school children will achieve the expected standard in reading, writing and maths by 2030, and the percentage of children meeting the expected standard in the worst performing areas, which need the most help, will have increased by more than a third. To meet our ambitious targets, the Schools Bill will go further, taking steps to make children safe and addressing standards in attendance, with this all underpinned by a fairer and stronger schools system. Because our best multi-academy trusts—those families of schools—are delivering improvement in schools and in areas where poor performance had become entrenched, by 2030 we want all schools either to be in a strong multi-academy trust or to have plans to join or form one.

Special Educational Needs and Disabilities Review

Debate between Jim Shannon and Nadhim Zahawi

Tuesday 29th March 2022 Commons Chamber

[Nadhim Zahawi]

I thank my hon. Friend for his thoughtful question. He is right that we intend to make a number of changes after consultation on the Green Paper, whether it is a national system so that parents can see exactly what provision they should be getting so that their area is consistent with every other postcode in the country, or whether it is a local plan co-produced with all stakeholders around the table—including parents—a local dashboard and consistency on EHCPs. In many ways, it is frustrating when parents say, “My plan and this person’s plan are completely different.” There should be consistency across the board to make the system as frictionless as possible for parents.

[Jim Shannon (Strangford) (DUP)]

I thank the Secretary of State for his positive statement. Covid-19 has been a big burden on pupils, and especially pupils with SEND. It is estimated that 25% of children are in that category. Our education system is incredible, but today’s statement is only the first step. Will the Secretary of State give a confirmed date for a review of the money put in to achieve the goal of giving that extra bit of help and, if necessary, a different way of working and delivering? Will the extra moneys, £2.6 billion plus £1 billion, be subject to the Barnett formula?

[Nadhim Zahawi]

I thank the hon. Gentleman for his excellent question. He is right to say this is the first step. I can come to the House to share this Green Paper, but we have to make sure the consultation is delivered, and then we have to ensure the implementation is in place. I asked the Treasury for £70 million to support the implementation. When I look back at the lessons learned, we fell over because there was little money for the implementation to happen well. Of course, Barnett applies to the Chancellor’s announcement on the spending review in the usual way.

Schools White Paper

Debate between Jim Shannon and Nadhim Zahawi

Monday 28th March 2022 Commons Chamber

[Nadhim Zahawi]

Yes, I can.

[Jim Shannon (Strangford) (DUP)]

I thank the Secretary of State for his statement. The parent pledge that the Secretary of State delivered today is ambitious and entirely necessary. A report in Northern Ireland has shown that children are eight months behind where they would normally be. The White Paper today is for England and Wales, but the problem is UK-wide, so the solution must also be UK-wide. What discussions has the Secretary of State had with devolved counterparts to ensure that this is the approach in every area of the United Kingdom?

Higher Education Reform

Debate between Jim Shannon and Nadhim Zahawi

Thursday 24th February 2022 Commons Chamber

[Nadhim Zahawi]

I commend my right hon. Friend for his excellent work on the Augar panel. He is a passionate advocate for the sector.

With your indulgence, Mr Deputy Speaker, I remind the House that, of every four international students, the United States take two, the United Kingdom takes one and the rest of the world shares one. That is how successful our higher education institutions are and have been. My right hon. Friend raises an important point, and this is a real consultation. I will take on board his suggestions and take a proper look at them.

[Jim Shannon (Strangford) (DUP)]

I thank the Secretary of State for his statement. Many of my constituents in Strangford and people across Northern Ireland attend universities here on the mainland to pursue a career in health. Has consideration been given to helping our health service by waiving fees and giving bursaries to those studying severely understaffed medical disciplines such as optometry, where cataract removal waiting lists are up to three years, and orthopaedics, where the waiting list for hip replacements is up to five years? Will the Secretary of State confirm that the Department for Education will work with the Department of Health and Social Care for the betterment of all throughout the United Kingdom of Great Britain and Northern Ireland?

[Nadhim Zahawi]

The hon. Gentleman will know that we already work very closely with the Department of Health and Social Care to make sure we hit our target of 50,000 more nurses. We always keep that work and the bursaries we offer under review to make sure we continue creating sufficiency so that we have a world-beating NHS.

Education: Return in January

Debate between Jim Shannon and Nadhim Zahawi

Wednesday 5th January 2022 Commons Chamber

[Nadhim Zahawi]

Absolutely. We managed to secure further funding in the spending review, so the total amount of funding going into catch-up is now just short of £5 billion—I think it is £4.9 billion. Those students who have the least time left in education—that is, 16 to 19-year-olds—are getting, in effect, an additional 40 hours of education, because it is important that we focus on their catch-up. Secondary and primary schools focus very much on disadvantaged students.

The major tutoring programme through which we are delivering 6 million tutoring sessions, each of which is, in effect, 15 hours of tutoring for those kids, means that we are seeing a real difference in outcomes. Tuition used to be the luxury of the very wealthy, but we want to make sure that every child has it available to them and I want parents to make sure that they ask schools what they are doing about the additional tuition that we are making available.

[Jim Shannon (Strangford) (DUP)]

I thank the right hon. Gentleman for his positive statement. What discussions have been held with the devolved Administrations and the Northern Ireland Assembly to ensure that the focus is on ensuring that children—particularly those with big exams coming up, whether GCSEs or A-levels—are taught at school? Furthermore, will additional funding be available for schools to run catch-up classes as and when they are needed?

[Nadhim Zahawi]

I mentioned earlier the funding settlement in the SR, and when I talk to school leaders, they say that they think that has been a good outcome for us in education. Of course, I also spoke about the £5 billion of catch-up funding. We are sometimes in danger of getting into an arms race in respect of how much we can announce, but my focus is on output: how many children have we managed to get to catch up, whether through the tuition partners scheme or any of the other schemes I have mentioned?

Skills and Post-16 Education Bill [Lords]

Debate between Jim Shannon and Nadhim Zahawi

2nd reading
Monday 15th November 2021 Commons Chamber

[Nadhim Zahawi]

The hon. Lady may recall that I first joined the Department for Education as apprenticeships tsar; I hope to talk about that later in my speech. I introduced the standards and the levy, and we did incredibly well in pushing quality ahead of quantity. It is very important for this House to focus on outcomes rather than just inputs.

Skills, schools and families—this is our mantra. Skills are about investing in people all across our country, about strengthening local economies, about productivity, about stabilising the labour market and about global competitiveness. They are about shoring up—and shoring ourselves up—for a better, stronger, more prosperous future. This is not a pipe dream; we are getting it done right now.

In January, our White Paper “Skills for Jobs” set out our plan to reform the skills system. I pay tribute to my predecessor, my right hon. Friend the Member for South Staffordshire (Gavin Williamson), for his work on that brilliant White Paper; I will not repeat everything that it said, because I am sure that hon. Members will have familiarised themselves with it, but I hope to show how we have acted on it.

First, we have significantly increased investment. We are investing £3.8 billion more in further education and skills over the Parliament by 2024-25. As the Chair of the Select Committee on Education, my right hon. Friend the Member for Harlow (Robert Halfon), said earlier this month, that is

“a remarkable amount of money for skills.”

I note the cross-party support for the measure in the Bill. Lord Sainsbury, who led an independent panel on skills on behalf of the coalition Government, is a big supporter of our plans. As President Truman once said, it is amazing what you can accomplish if you don’t care who gets the credit. That is what we are trying to do, and I hope that the Opposition will join us tonight: to work together to level up the skills base across our great country.

We are delivering an extra £1.6 billion boost by 2024-25 for 16 to 19-year-olds’ education, including maintaining funding in real terms per student and delivering more hours of teaching for T-levels. There is an extra hour a week for all students in that age group, who have the least time to catch up from covid. Apprenticeships funding will increase to £2.7 billion by 2024-25 to support businesses of all sizes to build the skilled workforce that they need. We are making vital improvements to FE college buildings and equipment across England, and we are delivering on our National Skills Fund manifesto commitment to help transform the lives of people who have not got on to the work ladder and who lack qualifications.

[Jim Shannon (Strangford) (DUP)]

I welcome the Bill, and I welcome what the Government are indicating that they wish to do, but may I ask a quick question? Only 26% of disadvantaged white British boys and 35% of disadvantaged white British girls achieve five good GCSEs including English and mathematics. What is happening to those young boys and girls who are not obtaining all the qualifications that they need in order to advance themselves and gain employment?

[Nadhim Zahawi]

The Education Committee did a very important piece of work on that precise subject. We are investing in recovery—investing £5 billion, following the Budget. We are investing in tutoring, and, of course we are investing in the quality of teaching. There cannot be great outcomes without great teachers, and we are providing 500,000 teaching opportunities.

I will now make some headway, if I may. As you quite rightly told me, Madam Deputy Speaker, many other Members wish to contribute tonight.

As well as the National Skills Fund manifesto commitment to help transform the lives of people who do not have the opportunities that many of us in this place have had, we are implementing the policies in the White Paper. For example, we have established eight trailblazer areas across the country where the first local skills improvement plans are being developed by employer representative bodies. They are currently engaging employers, education providers and key local stakeholders to begin the development of these important plans in the context of the skills landscape. The trailblazers are in areas from Kent to Cumbria, and they will generate valuable learning to inform the wider roll-out of these plans across our country.

The Bill also specifies the essential legal framework for our reforms. We are setting ourselves up for success by giving people the skills and education that they need for work by improving the quality of what they learn, and, of course, by protecting our learners from the disruptive impact of provider failure, reducing the risk that they will miss out on vital learning because, for example, the training provider with which they are studying goes bust.

I have seen at first hand the transformative power of education, and I want to take a moment to retell the House about an experience that I had while visiting Barnsley College. It was the first in south Yorkshire to roll out T-levels, and while I was there I met several of its students. I want to tell the House about one of them. I have rarely met a more inspiring individual. He told me that with his T-level—I am quoting him word for word—“I am looking at unis now and thinking which one I am picking, not which one is going to pick me.” Greg is living proof of the transformative effect that our skills programme is having.

I also met students at Barnet and Southgate College, during my first week in my present post, and saw how state-of-the-art facilities were helping those with learning difficulties and disabilities to realise their ambitions. The college is going further by strengthening its ties to local businesses: it has worked closely with its local chambers of commerce to provide a range of services for local businesses as a hub in the college. So our reforms are working, and they are very much evidence-led. They are changing people’s lives and levelling up the country, and the Bill will help to secure them for the years to come.

Covid-19 Vaccinations: 12 to 15-year-olds

Debate between Jim Shannon and Nadhim Zahawi

Monday 13th September 2021 Commons Chamber

[Nadhim Zahawi]

I remind the House that the chief medical officers looked at the mental health impact on children before making their decision today. That was an important aspect of their deliberations, and as I have said, the JCVI was in the room as well as the royal colleges. It is also important to remind the House that vaccination will be voluntary, and that no parent or child should be stigmatised in any way. As with our vaccination programme, this is about making all the information available and letting people make their mind up as to whether they want their child to be vaccinated.

[Jim Shannon (Strangford) (DUP)]

Can the Minister confirm that, as with all medical decisions for under 16-year-olds, the decision will always lie with the parent or the person with parental responsibility, and not with the child? Will the Minister state clearly for all to hear that this Government will continue to embrace autonomy and not enforce mandatory vaccination at any time, as has been done in communist regimes to the detriment of freedom and democracy?

[Nadhim Zahawi]

I remind the hon. Gentleman of the answers I gave earlier on consent. Parental consent will be sought, and the school-age vaccination programme is very well equipped to do that. The consent process is being handled by each school in its usual way and will provide sufficient time for parents to provide their consent. Children aged 12 to 15 will also be provided with information, usually in the form of a leaflet, for their own use and to share and discuss with their parents. The consent of the parent, guardian or carer will be sought by the school. In the rare circumstances in which a parent withholds consent but the child wants to be vaccinated, the child has to be deemed competent by the clinicians after consultation between the child and the parent. If that consultation is unsuccessful, the child has to be deemed to be Gillick competent. That has been the law of the land for other vaccination programmes, and in those circumstances the vaccination would proceed.

Covid-19: Immunology Research

Debate between Jim Shannon and Nadhim Zahawi

Thursday 9th September 2021 Westminster Hall

[The Minister for Covid Vaccine Deployment (Nadhim Zahawi)]

Thank you very much, Dr Huq. It is a pleasure to be here, in person, to serve under your chairship. I thank the hon. Member for Strangford (Jim Shannon) for securing this debate, and of course the hon. Members for Tooting (Dr Allin-Khan) and for Airdrie and Shotts (Anum Qaisar-Javed).

The shadow Minister referred to Edward Jenner and Blossom, and of course we all owe a huge debt of gratitude to Dame Sarah Gilbert, who now has a Barbie from Mattel in her image. I hope that will encourage many young kids to take up science, as a number of us in this Chamber have done. As I am sure colleagues here know, I am a proud chemical engineer from University College London. I think it appropriate, on a day like this, to congratulate the behind-the-scenes group—as the shadow Minister referred to them—of incredible scientists, whose incredible work has allowed us to deal with this pandemic. I am sure the whole House would want to join me in that.

I also congratulate Sir Shankar Balasubramanian and Sir David Klenerman. They have just received the $3 million Breakthrough Prize, which is referred to as the “Oscars of science” for their work at Cambridge on next-generation genome sequencing. To bring that to life for the House, it took $3 billion and about 10 years to sequence the first human genome. Their work on next-generation genome sequencing now allows that same work to take an hour and about $1,000, which makes a real contribution to future discovery.

For those who do not know her, I would also encourage people to look at the work of Professor Katalin Karikó, who has also been awarded the Breakthrough Prize today. She is not from the United Kingdom, but has had to travel a long journey, from Hungary to the USA and the University of Pennsylvania. Her personal struggle and her work on mRNA allowed BioNTech and Moderna, using her patents, to develop those incredible vaccines.

By calling this debate, the hon. Member for Strangford has really provided us with an opportunity to discuss the world-leading contributions that UK researchers have made by increasing our ability to tackle this disease. Investment by the Government has assisted the science underpinning the development of many of the tools we need to harness to ultimately defeat this virus.

UK-based research has provided insights that are crucial to improving surveillance, patient care and management, and developing new diagnostics, therapies and vaccines. Identifying how the immune system responds to covid-19 is critical to understanding so many of the unknowns around this novel virus. For example, why does it make some people sick and not others? What constitutes effective immunity and how long might that immunity last?

The immune system is extremely complex. To make rapid and effective progress in our knowledge, a nationally co-ordinated approach was needed, as the hon. Member for Strangford referred to. That is why £6.5 million of funding has been provided from UK Research and Innovation and the National Institute for Health Research to the UK Coronavirus Immunology Consortium. The UK is world leading in the quality of its immunology research, and this innovative project has enabled us in Government to commission at pace the research needed to understand the immunology of covid-19, and as a result successfully deliver real benefits to patients and public health. The key themes identified by UK-CIC included the understanding of primary immunity, and describing the body’s immune response to covid-19 and how this might explain the different risks presented by the virus to individuals. In other words, why do some get sicker than others?

What constitutes protective immunity? Identifying how an effective immune response can be generated and how it can be maintained to prevent re-infection was essential for the development of effective vaccines and understanding why some people remain vulnerable even after vaccination. Unpicking the mechanism of the disease caused by immunopathology—how the body’s own immune response to the virus can cause damage to tissues and organs, and how that can be stopped—is essential knowledge for the development of effective treatments, along with identifying immune vaccine evasion and how the virus might evade the body’s protective immune response through natural infection or vaccination, leaving people vulnerable to re-infection.

I want to highlight some further research that we have commissioned and funded in the field of diagnostics. The COVID-19 National DiagnOstic Research and Evaluation Platform—the CONDOR study—is accelerating how quickly promising diagnostics make it out of the lab and into real-world use. This will support the diagnosis of infection and the management of patients with suspected covid-19, which is important for the subsequent waves of infection in the post-pandemic setting.

On vaccine development and deployment, we all know the benefits that both doses of the vaccine can bring to many people. Indeed, colleagues have mentioned that today. Data from Public Health England suggests that two doses of the covid vaccine offer protection against hospitalisation of around 96%. The United Kingdom has been at the forefront of vaccine development, helped by the investment that we have made in this vital research. The ChAdOx1 vaccine platform—already shown to be safe and effective through a previously funded phase 1 trial against the middle east respiratory syndrome, or MERS, which the hon. Member for Strangford rightly referred to in his speech—was quickly adapted to develop a vaccine candidate against covid-19 and launched human trials in April 2020.

In parallel, project funding was also provided to investigate and develop more efficient vaccine manufacturing processes, enabling vaccines to be made more rapidly. However, the development of an effective vaccine is just the first step, and I commend the efforts of the NHS in the world-class roll-out of the vaccine programme among adults and young people across our four nations. Our efforts in understanding why some people do not develop a protective response even after receiving two doses of the vaccine are an important next step in our research portfolio, hence the Government have commissioned important studies to understand vaccine responses among the most vulnerable in our society.

However, despite the success of the current vaccination campaign, we are doing more by investing in research that will inform us about how to deliver vaccinations in the future and to help us to understand why some immunosuppressed people are not fully protected. I regularly meet charities that support clinically extremely vulnerable patients, and I share their concerns about the risks to this group from contracting covid-19.

There is a breadth of research activity being funded in order to look at vaccine response in immunocompromised individuals. The OCTAVE—observational cohort trial T cells antibodies and vaccine efficacy in SARS-CoV-2—study is examining covid-19 vaccine responses in clinically at-risk groups, including patients with certain immunosuppressed conditions. Building on the work that we did with the OCTAVE trial, we are funding OCTAVE DUO, which is a new clinical trial to determine whether a third dose of a vaccine will improve the immune response in people who have weakened immune systems. Additionally, the UKRI-funded research to be commissioned following the recent research on vaccine immune failure will investigate the strength and durability of the immune response, which I know colleagues are interested in understanding better in a wide range of people, including those with conditions that result in a weakened immune system, such as HIV.

The development of novel treatments for covid-19 has been made possible by the work and funding that we have provided for immunology research. As referred to by a number of hon. Members, that includes the UKRI and NIHR-funded projects looking at the immune response generated during infection with covid-19, which revealed that the body produces harmful immune responses that attack its own tissues and organs. That leads to severe disease and may underlie some forms of long covid, but further research is needed to better understand this. Research of this type has helped the development of new and effective treatment options, including the recently approved novel monoclonal antibody treatment Ronapreve. This novel treatment development was also supported by a UKRI and NIHR-funded trial.

I will briefly turn to some of the questions that hon. Members asked. The hon. Member for Strangford asked about long covid, which can have very serious and debilitating long-term effects for thousands of people across the UK. It can make daily life extremely challenging. We are providing significant funding for several studies in order to better understand the long covid problem, improve diagnosis and find new treatments. In July, the Department provided just shy of £20 million—I think it was £19.6 million—of funding towards an extensive programme of 15 new research studies, which will allow researchers across the UK to draw together their expertise from analysing long covid among people suffering long-term effects and the health and care professionals supporting them. The projects will better understand the condition and how to identify it, evaluate the effectiveness of different care services on people with long covid, identify effective treatments, such as drugs and rehabilitation, to treat people suffering from long covid, and improve home monitoring, which is a key issue.

[Jim Shannon]

I am very encouraged by that. Is it the intention of the Minister’s Department to share the results of those studies with all the different regions of the United Kingdom, so that we can all benefit? As health matters are devolved, the evidential base and final conclusion of the studies will be very important for us all.

[Nadhim Zahawi]

I completely share the hon. Gentleman’s concerns about that issue, and it is important that we look at it very seriously. He also asked whether we have enough supply of monoclonal antibody treatments. I can tell him that the regulatory approval and clinical policy will provide information on which patients could benefit from the treatments and how much supply is needed. We are working with the companies to ensure that we have a supply of those products in the coming months. Which patients are likely to have access to those treatments? Again, the NHS England antibody expert group is currently designing clinical guidance on how the NHS should use the treatments, which includes defining and identifying the eligible patient cohorts that are likely to benefit following a positive covid test.

In terms of deploying the treatments, part of the work of the NHS England expert group is on the clinical guidance on identifying potential deployment in hospital and possible pathways, especially through clinics and at-home services following a positive test. The hon. Gentleman also asked what research is looking at long-term immune response in individuals who are vaccinated. The Department is funding a number of important studies into immune response: the SARS-CoV-2 immunity and reinfection evaluation, or SIREN, study in healthcare workers; the Vivaldi study in care home residents and workers; and the coronavirus infection survey led by the Office for National Statistics, with repeat household visits looking at who has antibodies to covid from either vaccination or previous infection.

The hon. Gentleman asked about vaccine manufacturing in the longer term. I can tell him that in 2018, UKRI announced £66 million for the UK’s first dedicated vaccine manufacturing and innovation centre, VMIC. The goal was to promote, develop and accelerate the growth of the UK vaccine industry. When the pandemic began, UKRI reacted at unparalleled scale and speed to ensure that all investments were ready and able to respond to the challenge, and that they were plugged in to the UK’s wider vaccine, life science and pharmaceutical ecosystem. An additional £131 million was made available as an investment in, I think, May 2020, bringing the total for VMIC to just shy of £200 million, at £196 million. VMIC will be able to deliver about 200 million doses of vaccine, of any technology, at scale per annum, so it is a big investment.

The hon. Gentleman also asked what the Government are doing to support the development, production and procurement of vaccines for the future. As well as VMIC, we are planning for all scenarios in the fight against covid and its variants. Some of the recent analysis supports our understanding that both the Pfizer BioNTech and AstraZeneca vaccines currently being deployed in the UK appear to work well against the current dominant variants of covid, and continuing to administer those vaccines at scale remains our key to bringing the virus under control.

We are also assessing our existing portfolio against current variants, working closely with vaccine manufacturers and Public Health England, to understand the efficacy of our portfolio. We think we are in a good place vis-à-vis the interim advice from JCVI on the booster campaign, which we hope to begin later this month.

Finally, the hon. Gentleman asked whether there was any existing research that had helped to accelerate the development of vaccines. He quite rightly cited the work of the Oxford team, but even before the covid-19 pandemic, they were already doing that research because of funding from UKRI—and thank goodness for that.

To conclude, I fully recognise the tremendous impact that the pandemic has had on so many people. Commissioning high-quality immunology research is an essential part of our armoury in fighting this virus. We will continue to implement research findings and, at the same time, commission and fund new projects that will deepen our understanding of the disease and identify further defences that will keep us safe. Throughout this pandemic, the Government have been there to support and invest in research. As we shift our focus from the initial impact of the pandemic, we intend to continue to provide funding and support for covid-19 research, underlining precisely why the UK has long been, and continues to be, a great place for world-leading research and researchers.

Covid Vaccine Passports

Debate between Jim Shannon and Nadhim Zahawi

Wednesday 8th September 2021 Commons Chamber

[Nadhim Zahawi]

We will set out in detail in due course exactly how the vaccine pass will work for domestic use: for example, in nightclubs.

[Jim Shannon (Strangford) (DUP)]

I thank the Minister for all the hard work he does and for answering these very difficult questions. It would seem that each region of the United Kingdom of Great Britain and Northern Ireland has differing versions of the system in relation to offering vaccine passports, and that confuses people whenever they read or hear it in the national news. What discussions have taken place with regional Administrations on this issue? Are there any plans to standardise each region to have a one-size-fits-all UK strategy that people can understand and follow?

[Nadhim Zahawi]

I am grateful for the hon. Gentleman’s excellent question. I am very proud, as are the Ministers from the devolved Administrations, of the work we have done collectively on the vaccination programme, which we will continue to do for the booster programme. As he heard earlier, this is a devolved matter but we try to co-ordinate wherever possible and do the right thing together.

Covid-19 Update

Debate between Jim Shannon and Nadhim Zahawi

Monday 6th September 2021 Commons Chamber

[Jim Shannon (Strangford) (DUP)]

I thank the Minister for his statement. Can he reaffirm that no child will be vaccinated without explicit parental consent, and that, should consent not be given, that will not affect the child’s education in terms of school outings, sporting events or residentials? Does he believe that this protection needs to be further enshrined in law?

[Nadhim Zahawi]

I repeat to the House that no decision has been made on vaccinating 12 to 15-year-olds. We have to allow the chief medical officers to do the work that they need to do, with the JCVI in the room, and to come back to us. I will return to the House and share with Members the decision that is made. In terms of school-age vaccination programmes in general, parental consent is always required, and the NHS is well-versed in effectively receiving that consent. On the rare occasions when there is a difference of opinion between the child and the parents, the child’s competence and level of understanding of the vaccine come into play. NHS clinical advice is very much that that is a rarity, and parental consent is required for school-age vaccination programmes.

Covid-19 Update

Debate between Jim Shannon and Nadhim Zahawi

Thursday 22nd July 2021 Commons Chamber

[Nadhim Zahawi]

I am grateful for my right hon. Friend’s questions, as always: challenging but nevertheless the right challenges to think through. As I said, there are no easy decisions in what we are attempting to do. We will, I hope, be one of the first nations, certainly one of the largest economies in the world, that will see a transition of this virus from pandemic to endemic status—to manageable menace—through our vaccination programme, which is our primary tool.

The second most effective method is to make sure that people do self-isolate: I take on board his point and the point made by my right hon. Friend the Member for South West Surrey (Jeremy Hunt). That is why we are working flat out with critical infrastructure and key workers—of course with frontline NHS and social care staff, as I announced on Monday—to make sure that people have the ability to do a PCR test and then follow it up with a week or up to 10 days of daily lateral flow testing instead of self-isolation for 10 days. The honest truth is that there are no easy answers, because the very clear clinical advice and evidence is that if we do not do this carefully and slowly, we could risk the transition of the virus.

On the requirement around nightclubs by the end of September, I assure my right hon. Friend that we will be coming back to the House to make sure that it has an appropriate say on the matter. As we have seen with this virus in other countries, it is the right thing to do.

[Jim Shannon (Strangford) (DUP)]

I thank the Minister for his statement and for all that has been done on the covid-19 vaccine roll-out. The Northern Ireland Assembly’s Health Minister recently stated that at the end of July the closure of mass vaccination centres—for example, the SSE centre in Belfast—will come into force. The Minister in this House has today taken the opportunity through the press to urge people one last time to get the vaccine. Has he come to an assessment on the closure of mass vaccination centres in England, given the clear success of the vaccination process, and ever mindful that this autumn we will be doing a covid-19 vaccine booster process, which, along with the flu process, will add pressure to the health system? Will he ensure that there are options in place—for example, pharmacies and community centres—to bridge the gap?

[Nadhim Zahawi]

I thank the hon. Member for his excellent question. He is absolutely right. We are preparing a pretty ambitious vaccination programme, beginning in early September, for the covid boost. The interim advice from the JCVI could adjust as more clinical data comes through from the cov-boost trials that we are currently conducting. Wherever possible, we will co-administer flu vaccines at large scale. My big concern is that we have not had much flu circulating in communities and we could be in a position where in a bad flu year we could lose 20,000-plus people. Hence our ambitions are equally high for flu. We will look to co-administer wherever possible. We are looking to increase the number of pharmacies as well. We currently have over 600 pharmacies in the covid vaccination infrastructure, as well as the brilliant primary care networks, the hospitals and the vaccination centres. The cov-boost and the flu process will be equally ambitious as we look at the whole of the structure and how we utilise it, as well as making sure that GPs are able to get back to doing the work they need to do—looking after their patients.

Covid-19 Update

Debate between Jim Shannon and Nadhim Zahawi

Monday 19th July 2021 Commons Chamber

[Nadhim Zahawi]

I am grateful to my hon. Friend for his question. The vaccination rates in the United Kingdom have been incredibly high. We are at 88% with the first dose and 68% with double doses. On double doses, we are actually ahead of the United States of America. That does not mean we become complacent, however. We are doing everything we can to ensure that every cohort, and every ethnicity has the ability to access the vaccine.

Let me give him an example of some great work in the London Borough of Newham. Last week it had 23 different vaccination sites in pop-ups, in mosques, in GPs and in community pharmacies across the borough. Young people were literally tripping over a vaccine site. Part of it is access. Part of it is taking the vaccine to those communities. I am working with a number of colleagues to make sure we get into rural communities, for example with vaccine buses, and in community centres where people feel safe and comfortable to have the vaccine. The work does not end today. We continue to double down on our effort to continue vaccination. Again, I want to place on record my thanks to the metro Mayors for the work they do with us to make sure that happens as well.

[Jim Shannon (Strangford) (DUP)]

The Minister has been thanking everybody else, but I think we also need to thank the Minister, his Department, his team and the NHS staff for all they have done for the vaccine programme. Given recent news that those aged 12 to 17 will be offered a covid vaccination to protect them in the colder weather, has the Minister come to an assessment of how effective that will prove to limit the spread of covid-19 in schools? What discussions has he had with Education Ministers to deliver the vaccine roll-out?

[Nadhim Zahawi]

I am grateful to the hon. Member, who is always wonderfully complimentary and polite. I am grateful for his compliments and I will take them back to the team. We have conversations all the time. We are making preparations for the co-administration, wherever possible, of the flu vaccine with the covid boost, beginning early September, based on the interim advice from the JCVI. The only caveat is obviously that it is only interim advice and it could change as the JCVI gets more clinical data through. We have a big trial on seven of our vaccines to see which delivers the best boost possible. When it gets that data back, we will firm up that advice, but operationally we aim to begin in September.

Covid-19

Debate between Jim Shannon and Nadhim Zahawi

Tuesday 25th May 2021 Commons Chamber

[Nadhim Zahawi]

It is worth waiting for 14 June, when we will be saying more on this, but suffice it to say two things: first, even if someone has had two doses of either vaccine —I have had this experience in my own family—they can still contract covid and should therefore be isolating and quarantining; secondly, we are also looking at ways in which contacts of people who may have contracted covid can be regularly tested instead of isolating.

[Jim Shannon (Strangford) (DUP)]

I thank the Minister for his responses so far and for the magnificent effort. I had my second vaccine yesterday, and just to show how national that was, the person who gave me the injection was a doctor from Lincolnshire. I believe that this very much shows that the United Kingdom of Great Britain and Northern Ireland works better together, and that this is a supreme example of that.

We understand that things will change depending on the circumstances and that localised lockdowns may be the way to ensure that areas with low numbers are able to allow people to live safely. Can the Minister outline what parameters will establish localised lockdowns and tell us whether the same approach will be taken UK-wide by the devolved regions?

[Nadhim Zahawi]

I am very pleased to hear that my hon. Friend has had his second dose; when people get that text message, they should please come forward and have their second dose. We are looking to ensure that the whole country comes out of this together, hence the advice being very much about exercising caution and self-responsibility. People actually get this; we see in much of the research data that they know the things that can add to the risk and that they should therefore abstain from doing those things while we vaccinate at scale to get to the place where we can all hopefully get our lives back.

Covid-19 Vaccine Update

Debate between Jim Shannon and Nadhim Zahawi

Thursday 4th February 2021 Commons Chamber

[Nadhim Zahawi]

I want to reassure my hon. Friend that, through the vaccines taskforce, we have been liaising extensively with the vaccines’ developers and the related organisations to ensure that the highest level of security exists through the whole vaccine deployment chain. That has, of course, included working directly with the manufacturers, and we have a senior responsible officer seconded to the team to make sure that security is at the forefront of everything we do to deliver this programme. We cannot allow a lapse of security to get in the way of the largest vaccination programme in the history of this country.

[Jim Shannon (Strangford) (DUP)]

I thank the Minister for his concerted strategy and for the overall roll-out of covid vaccines. We are deeply indebted to him for the focus he has given. Does he intend there to be a route by which those who are younger and still attending front-facing work are able to access their vaccine? Furthermore, what co-ordination has there been with GPs’ surgeries to assist them in categorising need when assessing those who are vulnerable but who did not have shielding CEV letters?

[Nadhim Zahawi]

I am grateful to the hon. Gentleman for raising this issue. It is a priority for us and we will be saying more on it very soon, because the groups who have not received the letters but are shielding remain incredibly important. He is absolutely right to raise the issue, which is a priority for us.

Covid-19: Vaccinations

Debate between Jim Shannon and Nadhim Zahawi

Monday 11th January 2021 Commons Chamber

[Nadhim Zahawi]

I absolutely join my hon. Friend in congratulating and thanking the heroes of the NHS and the volunteers in Telford and Wrekin and Shropshire for vaccinating 15,000 people—15,000 of the most vulnerable people to covid who, in a couple of weeks’ time, will have that protection. He is right, I can confirm, that anyone receiving a letter where it is inappropriate or not possible for them to travel that distance to a national vaccination centre does not have to do so. They will be able to be vaccinated in their primary care network at a time and place that is convenient to them. With the national vaccination centres—seven went live today, and there will be more next week, more the week after and 50 in total by the end of the month—we are trying to effectively add to the throughput that I described earlier.

[Jim Shannon (Strangford) (DUP)]

I have some good news: my mother, who is 89 years young, had her vaccine at 9.40 this morning, so it is a happy day—I was going to sing it, but then it would start to rain, so it is not a good idea. What system is in place to ensure that if someone does not turn up for their vaccine, not one slot or vaccine goes to waste, and that a secondary list is immediately available with staff to substitute? At Dundonald hospital in Northern Ireland over the weekend, some people did not turn up, but they were able to call upon the midwives team to come forward. What policy is in place to make sure that the vaccine is not lost for use?

[Nadhim Zahawi]

The people of Strangford will be pleased to hear that the hon. Member’s mother has got her first a dose of the vaccine. This is an important message to send to the whole country: if you are called up and have an appointment to get the vaccine, please turn up. This vaccine can protect your life. It can protect somebody else’s life. It is a shame to not turn up if you have booked an appointment. The NHS in England has made sure that the hospital hubs and primary care networks that have been vaccinating, and now the national vaccination centres, have on speed dial the care home workers and those on the frontline of the battle against covid who are in the JCVI’s top four cohorts, so that they can get them in as quickly as possible and not a single dose is wasted.

Covid-19: Vaccination

Debate between Jim Shannon and Nadhim Zahawi

Monday 14th December 2020 Westminster Hall

[The Parliamentary Under-Secretary of State for Business, Energy and Industrial Strategy (Nadhim Zahawi)]

It is a pleasure to serve under your chairmanship, Sir David. I congratulate my hon. Friend the Member for Carshalton and Wallington (Elliot Colburn) on his leadership of this important debate on e-petition 323442. Over 300,000 people have signed the petition, including 641 in his constituency.

I am grateful to the hon. Member for Strangford (Jim Shannon) for his very moving speech, and I am deeply saddened by the loss of his mother-in-law and the infection of his wife, other family members and friends. As the shadow Minister rightly pointed out, the hon. Member for Strangford brought home that each and every statistic is a person, with a family and people who love them very much.

I will hopefully address the excellent—as always—speech by my hon. Friend the Member for Wycombe (Mr Baker). I am grateful to the hon. Member for North Ayrshire and Arran (Patricia Gibson) both for her excellent speech and for her clear confirmation that neither the Scottish Government nor the United Kingdom Government will mandate vaccination at all. I congratulate her chief medical officer, as well as the chief medical officers in Northern Ireland and Wales, who worked together so that we could all start to vaccinate on the same day, last Tuesday. I am grateful, Sir David, for the opportunity to speak on behalf of the Government this evening.

[Jim Shannon]

We in Northern Ireland were first.

[Nadhim Zahawi]

I hear the hon. Gentleman; Northern Ireland was first by a few minutes.

Last week was a most important week across the United Kingdom, because we began vaccinating people against covid-19, and that, I hope, has started to turn the tide on this virus. The pandemic has forced the Government and our devolved Administrations to take steps that are truly unprecedented in peacetime. They are steps that no democratic Government would wish to take unless they were absolutely necessary. At each point in the pandemic, every decision we have taken has been with the utmost consideration for its impact on our personal freedoms. As hon. Members have brilliantly highlighted this evening, and as my hon. Friend the Member for Wycombe rightly reminded us, the petition that we are debating is a matter of great legal and ethical complexity.

Before I address some of those complexities, I will set out the facts. First, there are currently no plans to place restrictions on those who refuse to have a covid vaccination. As my hon. Friend the Member for Carshalton and Wallington reminded us, we have no plans to introduce so-called vaccine passporting. My hon. Friend the Member for Wycombe was slightly nervous about that, quite rightly, as when I did my first interview about the issue—with the BBC, I think—I was asked about some of the technological challenges and I may have mis-spoken. I was grateful to The Spectator and TalkRadio, which allowed me to explain myself.

Mandating vaccinations is discriminatory and completely wrong, and, like my hon. Friend the Member for Wycombe and others, I urge businesses listening to this debate to not even think about that. I will explain in further detail why that is the wrong thing to do. I put on record my thanks to Professor Karol Sikora, who has many hundreds of thousands of followers, who quoted me and said I eloquently dealt with the issue. We have absolutely no plans for vaccine passporting.

Secondly, cards that were issued after people got their first covid-19 vaccination have been mentioned on social media. Among other details, they contain the date of their second vaccination. That record does not constitute a so-called vaccine passport. It does mean anyone is immune. As we know, the vaccine is given as two injections, 21 days apart. The second dose is the booster dose. I am sure hon. Members will forgive me for repeating the message that patients must return as instructed for their second dose. Without the second dose, the vaccine will not be effective. That is a really important message, and I am grateful to all hon. Members who are repeating that to their constituents.

Thirdly, on completion of both vaccinations, patients will be issued with a vaccine record card, much as they are for other vaccination programmes, so there is nothing different in the way we are dealing with this vaccine. Again, that does not constitute a so-called vaccine passport; nor can it be used as a form of identification. That would be absolutely wrong. Colleagues will appreciate that the careful and accurate recording of vaccination status is an important part of a public health effort. It supports patient safety during probably the largest and most challenging vaccination programme in British history.

Fourthly, in addressing the many who signed the petition, I want to underline one key fact, which we have heard over and over again from hon. Members: vaccines work. It is really important that we send that message from this place. After clean water, they are the single greatest public health tool in the history of mankind. My hon. Friend the Member for Carshalton and Wallington reminded us of Edward Jenner. It fills me with great joy that the Jenner Institute was one of the first to stand up and say, “We can do this.” I hope that, after a rigorous study by the Medicines and Healthcare Products Regulatory Agency, the Oxford-AstraZeneca vaccine will be in place as soon as approval comes through. Obviously it is up to the regulator to deliver that.

Vaccines, as we have heard, have ended untold suffering for millions, if not billions, of people around the world. When our turn comes and our GP gets in touch, we all have a duty to heed that call. It is how we will be able to protect ourselves and the people around us—our friends and family, the people we love. Months of trials, involving thousands of people, have shown that the vaccines we are using are effective. They work. In answer to my hon. Friend the Member for Carshalton and Wallington, they have been tested on between 15,000 and 50,000 people. There were no shortcuts or quick fixes by the MHRA; it has followed exactly the same process as usual. The difference is that instead of waiting for phase 1 to finish before doing phase 2, and then phase 3, the studies were in parallel; hence we were able to develop the vaccines rapidly.

Fifthly, and equally importantly, each covid vaccine will be authorised only, as I have said, once it has met robust standards of effectiveness, safety and quality. As we have heard, vaccines authorised by our independent regulator, the MHRA, will be assessed for clinical safety and effectiveness through a robust review. The vaccine is free to everyone eligible across the UK. There is really no excuse for someone not to take it when their turn comes.

Sixthly, although we know the vaccine protects individuals, we do not yet know its precise impact on onward transmission. My hon. Friend the Member for Wycombe made that point brilliantly himself, and by quoting the Secretary of State. In answer to the hon. Member for Nottingham North (Alex Norris), we will not know where the point is that he mentioned until we scale up the vaccinations. We will continue to monitor the impact on transmission through the Test and Trace system. As my hon. Friend the Member for Wycombe said, we do know that the vaccine protects people, which is the important thing. That is why I encourage everyone to read, read and read again—or to ask, ask and ask again, to quote the hon. Member for Nottingham North.

The full impact on infection rates will not become clear until we get to those large numbers, so we are monitoring that carefully. Hon. Members will understand that without our knowing that, it would be irresponsible for anyone to declare that they are immune. The Qantas question is therefore completely wrong, because it is impossible for anyone to say that. The science does not yet support that conclusion. Even if people are vaccinated, they must continue to follow the rules where they are, and keep taking the common-sense steps that are now so familiar to us—washing our hands, covering our face and making space.

Hon. Members have raised many questions about the World Health Organisation and the required international response. The United Kingdom Government have led the way. We could do even more. Next year, the UK will take up the presidency of the G7, as the hon. Member for Nottingham North mentioned; we will need to deal with anti-vaxxers nationally and internationally. We look forward to working with many nations on that challenge.

I will turn to some of the hon. Gentleman’s other questions. On GPs and the additional 15 minutes, that was the further guidance from the MHRA after two cases in which people with a history of severe allergies had an allergic reaction to the Pfizer-BioNTech vaccine. That is why there was a change to the process. On the roll-out today to primary care networks and the question about caseloads, it is brilliant that GPs have come together with primary care networks. For example, in an area of 50,000 people and five practices, they have come together and agreed that one would lead on the vaccination while the other four continued to support the community and deal with caseloads. On his question about care home staff who continue to be prioritised, I am happy to take that offline with him if he has a particular case or details.

The petition that we have debated is of profound importance. I urge anyone who is considering refusing a covid-19 vaccination to ask and ask again. Not only is the vaccine effective and proven to be clinically safe, but the quicker we are able to vaccinate people, the quicker we can bring forward the date when we can begin to lift the oppressive restrictions that were put in place with a truly heavy heart. I came from a world of entrepreneurialism, of unleashing people’s ingenuity, energy and passion. I did not enter politics to restrict people’s freedoms, which I profoundly believe in. In the meantime, we all have our part to play. We must continue to respect the rules to ensure that the efforts succeed and can be our shared success, so that we can all have a more joyous 2021. If I do my job properly, we will all be back in this Chamber celebrating, I hope, without the restrictions that we have today.

Nuclear Energy Policy: Climate Change

Debate between Jim Shannon and Nadhim Zahawi

Wednesday 5th February 2020 Commons Chamber

[Nadhim Zahawi]

Quite right, Sir. It has been over three decades since Ynys Môn elected a Conservative Member of Parliament and I look forward to working with her over the coming years to ensure that this Government deliver for the people of her constituency and across the entire region of north Wales.

I am pleased that my hon. Friend has raised the important issue of nuclear energy, and I am eager to speak to her and the House this evening about the huge number of benefits that the UK expects to receive as a result of the Government’s commitment to the sector. I am grateful to the Secretary of State for Work and Pensions, my right hon. Friend the Member for Suffolk Coastal (Dr Coffey), for her presence. She, too, takes an eager interest in nuclear power, not only because of her constituency and her constituents’ needs, but for the wellbeing of the energy sector nationally.

New nuclear is likely to have a significant role to play in reducing greenhouse gas emissions to net zero by 2050. In September 2016, we gave the go-ahead to the first new nuclear power station in a generation, at Hinkley Point C; and in June 2018 we committed £200 million through our landmark nuclear sector deal, which includes millions of pounds for advanced nuclear technologies. The Government understand the important role that nuclear plays, and will continue to play, in our economy. That role includes ensuring that local and national benefits are realised, whether through increased employment opportunities or improvements in skills.

As my hon. Friend the Member for Ynys Môn reminded us, on 27 June 2019 the UK Government set a legally binding target to achieve net zero greenhouse gas emissions from across the whole UK economy by 2050. We were the first major economy in the world—followed by France and the rest of the EU—to legislate for net zero, and we want to deliver our commitments in a way that maximises the economic benefits of the transition to net zero. Between 1990 and 2017, we reduced emissions by more than 40% while at the same time growing our economy by more than two thirds, decarbonising our economy faster than any other G20 country. The net zero target requires us to build on that progress by transforming the whole of our economy and, of course, changing the culture in our society—our homes, our transport, our businesses and how we generate and use energy.

I thank my hon. Friend for talking about the energy White Paper. It will form a key part of our journey to net zero. To answer her question about its publication date, I can inform her that the Secretary of State has stated that she intends to publish the energy White Paper in the first quarter of this year. The White Paper will set out a clear, decisive strategy—a strategic approach to decarbonising energy, driving up clean growth opportunities and demonstrating international leadership in the build-up to COP26 at the end of the year. I am sure we are all delighted that COP26 is to be hosted in the great Scottish city of Glasgow.

Net zero is not just good for the environment; it is good business. It is already abundantly clear, however, that a substantial increase in low-carbon generation will be needed to reach net zero by 2050. Nuclear will have an important role to play in the UK’s future energy mix, providing firm low-carbon power and complementing variable renewable generation. Britain was the world’s first civil nuclear nation, and nuclear energy has powered homes and businesses in this country for more than 60 years. There are currently 15 nuclear reactors operating at eight sites throughout the UK, and they provide a fifth of our electricity. In 2016, the Government gave the go-ahead for the first new nuclear power station in a generation, at Hinkley Point C in Somerset. Once operational, Hinkley will provide 3.2 GW of secure, low-carbon electricity for around 60 years, meeting an estimated 7% of the UK’s current electricity requirements. To put that another way, it will power nearly 6 million British homes—twice as many homes as there are in London.

I recently had the pleasure of visiting the Hinkley site, and it was incredible to see the sheer scale of the endeavour that is being undertaken. There has been significant progress at the site; in December, the developer announced that all key milestones for 2019 had been achieved. Those included the successful delivery of J-zero for the first reactor, which marked the point at which the foundations for unit 1 were complete and the above-ground work could commence. They also included the first big lift for Big Carl—who I met—the world’s largest land-based crane, which towers 250 metres over the site. In one single lift, it can lift the equivalent weight of 5,000 shire horses, or of two A380s. It is a remarkable piece of engineering. On 18 December, engineers at Hinkley worked through the night to lift a 170 tonne part of the reactor’s steel containment liner into place, and it was fantastic to see the results at first hand.

During its construction and operation, Hinkley Point C will provide the local region, as well as the entirety of the UK, with economic benefits. In July 2018, the Government published “Hinkley Point C: wider benefits realisation plan”. The plan, produced with support from EDF Energy, sets out how the wider benefits of the project will be delivered. For example, Hinkley Point C is expected to provide more than 25,000 new employment opportunities and up to 64% of the value of construction contracts to UK-registered companies.

[Jim Shannon]

During the previous Parliament, I met some of the people involved in the project. They told me that all regions of the United Kingdom of Great Britain and Northern Ireland would benefit from those jobs. Can the Minister confirm that Northern Ireland will gain from the construction of the project?

[Nadhim Zahawi]

I am grateful to my hon. Friend for that question. I am happy to write back to him on how much of the benefit has gone to businesses in Northern Ireland.

A total of almost £4 billion in today’s money will go into the regional economy over the lifetime of the project, composed of about £1.5 billion during construction and about £2.4 billion during operations.